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Analysis of Amplified Genes in Samples of Pleomorphic 
Adenoma and Carcinoma Ex Pleomorphic Adenoma by 
CGH-Array Technique
Erika Egal, Welligton Sabino1, João Scarini, DDS1, 
Reydson Souza, DDS1, Albina Altemani, MD, PhD1, 
Alfio Tincani, MD, PhD1, Andre Del Negro, MD, PhD1, 
Luiz Paulo Kowaski, MD, PhD2, Fernanda Mariano, DDS, 
MSc, PhD1; 1Unicamp 2AC Camargo Cancer Center
Introduction: Pleomorphic adenoma (PA) is a benign 
lesion of  the salivary glands that can suffer malignant 
transformation to carcinoma ex adenoma pleomorphic 
(CXPA). The pathogenesis of  CXPA has been attributed 
to the accumulation of  genetic disorders in preexisting 
PAs. However, there is no confirmation whether there is 
a common target gene involved in all histopathological 
subtypes or the decisive factors for malignant transfor-
mation in a histopathological subtype are specific.
Objectives: To further analyze genes found in PA and CXPA 
using the CGH-array technique. The genes found were analyzed 
using the InteractiVenn virtual tool (http://www.interactivenn.
net/) and grouped into a Microsoft Excel worksheet.
Results: Of the 460 genes amplified in the studied sam-
ples, 287 (62.4%) were related only to CXPA, whereas 144 
(31.3%) were related to residual PA. Twenty-nine (6.3%) 
of these genes were common between residual PA and 
CXPA. Regarding the degree of invasion of CXPA, there 
was an increase in the number of genes amplified as the 
degree of invasion and aggression increased: 8 genes re-
lated to intracapsular CXPA, 65 to minimally invasive 
CXPA, and 373 to weakly invasive. Moreover, when com-
paring residual AP and intracapsular CXPA, two genes 
were common to these groups: ERRB2 and GRB7. As for 
the histological subtype, the high-grade samples had more 
amplifications (320 amplified genes) than the low-grade 
ones (129 genes). Three of these genes were common 
among residual PAs and CXPA: HMGA2, RPSAP52, and 
LOC100129940. As for the replicates, MYNC, ERBB2, 
BRIP1, and HMGA2 were the most repeated amplified 
genes in the residual PAs. HMGA2, ERRBB2, CDK12, 
RPSAP52, LOC100129940, and LOC100507250 were the 
genes with the most replicates in CXPA.
Conclusion: HMGA2, ERRB2, and RPSAP52 may play 
a key role in PA carcinogenesis, whereas GRB7, CDK12, 
MYNC, and BRIP1 appear to act as coadjutants.
B-Cell lymphoma 2 Protein Expression and Established 
Clinicopathologic Features in Breast Cancers
Yan Xiang1, Li Li2, Mark Zarella, PhD3, Katarzyna 
Brzezinska3, Kareem Hosny, MD, MPH3, Steve Hou3, 
Fernando Garcia, MD4; 1Drexel University 2Icahn School 
of Medicine at Mount Sinai 3Drexel University College of 
Medicine 4Eastern Regional Medical Center/CTCA
Objectives: B-cell lymphoma 2 (Bcl-2) proto-oncogene 
alterations are involved in tumor genesis and play a 
vital role in regulating cell apoptosis. The objective of 
this research is to determine the prognostic value of 
quantitative expression of  the Bcl-2 protein in breast 
cancer.
Methods: This study investigated a series of 158 primary 
breast cancers for Bcl-2 protein expression. Results were 
correlated with clinicopathologic features (age, tumor 
size, tubule formation, nuclear pleomorphism, mitotic 
count, and Nottingham prognostic index: NPI) and a 
panel of markers of established or presumed predictive 
values.
Results: Bcl-2 H-score (multiplied by staining intensity 
and percentage of positive cells) was observed to have a 
significant reversed correlation with the Magee Equation 
1, 2, 3 (P1  < .001, P2  < .001, P3  < .001, r1  =  –0.36, 
r2 = –0.34, r3 = –0.34). High proliferative activity as as-
sessed by Ki-67 (>25%) staining negatively associated 
with Bcl-2 H-score (P = .03). Low Bcl-2 H-score was as-
sociated with old age (age >63, P = .039). Bcl-2 cytoplasm 
percent positive score was negatively associated (P = .02, 
n = 92) with overexpression of p53 (positive percentage 
>1.5). High Bcl-2 H-score was also associated with tumor 
size (T >1.5 cm, P =  .034), but there was no significant 
correlation observed between Bcl-2 expression and the 
NPI calculated using the size of the lesion, the number of 
involved lymph nodes, and the grade of the tumor (NPI 
>3.4, P = .317).
Conclusion: (1) This study reports a correlation between 
Bcl-2 H-score and all three Magee equation values. (2) 
Bcl-2 H-score provides prognostic value better than per-
centage of positive cells. (3) This study further reports 
a correlation between Bcl-2 H-score and age, tumor 
size, Ki-67, and p53, irrespective of the type of adju-
vant therapy received and across molecular subtypes. 
Collectively, these results establish the rationale for intro-
duction of semiquantitative expression of the Bcl-2 pro-
tein to improve prognostic stratification of breast cancer 
patients.
Rare Case of Metastatic Ovarian Clear Cell Carcinoma 
With an In Vitro Fertilization Pregnancy
Arati Inamdar, MD, PhD1, Abraham Loo1; 1RWJ 
Barnabas Health
The risk of ovarian malignancy is rare in pregnancy 
with a reported incidence of approximately 1 in 50,000. 
Ovarian clear cell carcinoma (OCCC) accounts for 5% to 
10% of all ovarian carcinomas with mean age of 50 to 
55 years and is often associated with endometriosis. We 
present a case of 38-year-old G2P1 Asian female with 
an in vitro fertilization pregnancy and history of endo-
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